enVVeno Medical Corporation

About:

Hancock Jaffe Laboratories develops bioprosthetic devices for cardiovascular surgeries.

Top Investors: Perceptive Advisors, Nantahala Capital Management, Kingdon Capital, L1 Capital, Velan Capital

Description:

Hancock Jaffe Laboratories develops life-enhancing bioprosthetic devices and technologies intended to achieve unparalleled outcomes for patients with debilitating cardiovascular diseases. Each device is designed to allow vascular and cardiothoracic surgeons to achieve maximum effectiveness while greatly reducing the time and complexity of current procedures in concert with a commitment to efficient health care delivery. Founded in 1987 by Norman Jaffe, Hancock Jaffe Laboratories is headquartered in Irvine, California.

Total Funding Amount:

$107M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

1987-01-01

Founders:

Norman Jaffe

Number of Employees:

11-50

Last Funding Date:

2024-09-26

IPO Status:

Public

Industries: